2014 annual financial data
Halozyme Therapeutics 2014 Operating margin
Direct answer
Operating margin was -83.68%.
Operating income was -63,036,000 USD and net income was -68,375,000 USD.
Operating cash flow was -47,518,000 USD.
Get free Halozyme Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 75,334,000 USD
- Operating income
- -63,036,000 USD
- Net income
- -68,375,000 USD
- Operating cash flow
- -47,518,000 USD